Original Biotech Launches Innovative Mulberry Extract with DNJ 1.0-10.0%

Original Biotech is excited to announce the launch of its latest product, a high-quality Mulberry Extract featuring DNJ (Deoxynojirimycin) concentrations ranging from 1.0% to 10.0%. This new product is designed to meet diverse customer needs, offering both low pesticide residue specifications and a granular grade option.

The Mulberry Extract from Original Biotech is produced with a focus on stability and consistency, ensuring that each batch meets the highest quality standards. DNJ, a potent natural compound found in mulberries, is known for its potential health benefits, including regulating blood sugar levels and supporting metabolic health.

"We are thrilled to introduce our new Mulberry Extract with DNJ 1.0-10.0% to the market," said Bruce Wen, spokesperson for Original Biotech. "Our team has worked diligently to develop a product that not only offers the therapeutic benefits of mulberry extract but also adheres to stringent safety and quality standards. The availability of low pesticide residue and granular grade options further enhances the versatility and appeal of our product."

Original Biotech's Mulberry Extract is produced using state-of-the-art technology and stringent quality control measures to ensure the highest purity and efficacy. This product launch aligns with the company's commitment to innovation and excellence in the biotechnology industry.

For more information about Original Biotech and its new Mulberry Extract, please visit contact us at sales@origbiotech.com.